tokbokki/tatqa_dataset_filter huggingface dataset:
text: NOTE 11 - STOCK CAPITAL (Cont.)
text: Shares and warrants issued to service providers:
text: On August 17, 2017 the Company issued to Anthony Fiorino, the former CEO of the Company, for consulting services rendered, a grant of 4,327 shares of restricted stock under the 2014 U.S. Plan, which vests in eight equal quarterly installments (starting November 17, 2017) until fully vested on the second anniversary of the date of grant.
text: Compensation expense recorded by the Company in respect of its stock-based service provider compensation awards for the year ended December 31, 2019 and 2018 amounted to $25 and $102, respectively.
text: On March 26, 2019, the Company issued to its legal advisor 5,908 shares of Common Stock under the 2014 U.S. Plan for certain 2018 legal services. The related compensation expense was recorded as general and administrative expense in 2018.
text: On May 23, 2019, the Company granted to a former director, in consideration for services rendered to the Company, an option under the 2014 Global Plan to purchase up to 4,167 shares of Common Stock with an exercise price per share of $0.75. The option was fully vested and exercisable as of the date of grant.
text: Total Stock-Based Compensation Expense:
text: The total stock-based compensation expense, related to shares, options and warrants granted to employees, directors and service providers was comprised, at each period, as follows:

Table:
December 31
2019
2 0 1 8
U.S. $ in thousands
Research and development
123
175
General and administrative
666
844
Total stock-based compensation expense
789
1,019

Questions:
question: What is the change in the research and development stock-based compensation expense from 2018 to 2019?
answer: -52
derivation: 123-175
scale: thousand
question: What is the change in the general and administrative stock-based compensation expense from 2018 to 2019?
answer: -178
derivation: 666-844
scale: thousand
text: The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities at each fiscal year-end are presented below (in thousands):
text: The Tax Act was enacted into law on December 22, 2017. The Tax Act included a reduction in the U.S. federal statutory corporate income tax rate (the “Tax Rate”) from 35% to 21% and introduced new limitations on certain business deductions. As a result, for the fiscal year ended September 30, 2018, we recognized a year-to-date, non-cash $32.5 million tax provision expense impact primarily related to the re-measurement of our deferred tax assets and liabilities due to the reduced Tax Rate.
text: Deferred tax assets as of September 29, 2019 include state net operating loss carry-forwards of approximately$27.4 million expiring at various times between 2020 and 2038. At September 29, 2019, we recorded a valuation allowance of$2.5 million related to losses and state tax credits, which decreased from the$3.6 million at September 30, 2018 primarily due to the release of the valuation allowance on prior year net operating losses. We believe that it is more likely than not that these net operating loss and credit carry-forwards will not be realized and that all other deferred tax assets will be realized through future taxable income or alternative tax strategies.
text: The major jurisdictions in which the Company files income tax returns include the United States and states in which we operate that impose an income tax. The federal statutes of limitations have not expired for fiscal years 2016 and forward. The statutes of limitations for California and Texas, which constitute the Company’s major state tax jurisdictions, have not expired for fiscal years 2015 and forward.

Table:
2019
2018
Deferred tax assets:
Accrued defined benefit pension and postretirement benefits
$46,918
$34,776
Deferred income
13,803
1,535
Impairment
9,981
11,388
Accrued insurance
7,133
8,994
Share-based compensation
5,415
4,936
Tax loss and tax credit carryforwards
5,327
7,458
Lease commitments related to closed or refranchised locations
3,786
4,696
Deferred interest deduction
3,188
—
Other reserves and allowances
2,965
851
Accrued incentive compensation
2,617
2,055
Accrued compensation expense
1,092
2,034
Interest rate swaps
—
181
Other, net
868
2,206
Total gross deferred tax assets
103,093
81,110
Valuation allowance
(2,485)
(3,554)
Total net deferred tax assets
100,608
77,556
Deferred tax liabilities:
Intangible assets
(10,520)
(10,492)
Leasing transactions
(3,822)
(2,790)
Property and equipment, principally due to differences in depreciation
(128)
(1,855)
Other
(574)
(279)
Total gross deferred tax liabilities
(15,044)
(15,416)
Net deferred tax assets
$85,564
$62,140

Questions:
question: What is the percentage change in accrued incentive compensation from 2018 to 2019?
answer: 27.35
derivation: (2,617-2,055)/2,055
scale: percent
text: Consolidated Statements of Earnings and Comprehensive Earnings
text: A detail of related party items included in Operating expenses (net of expense reimbursements) is as follows (in millions):
text: (1) Transactions with FNF are summarized through November 30, 2019, the date after which FNF is no longer considered a related party.

Table:
Year ended December 31,
2019(1)
2018
2017
Data entry, indexing services and other operating expenses
$8.8
$8.2
$5.1
Corporate services
3.8
4.9
9.2
Technology and corporate services
(0.1)
(1.0)
(1.7)
Total related party expenses, net
$12.5
$12.1
$12.6

Questions:
question: What was the percentage change in Technology and corporate services between 2017 and 2018?
answer: -41.18
derivation: (-1.0-(-1.7))/-1.7
scale: percent
text: Revenue
text: Revenue was $5,517.9 million and $5,878.3 million for 2019 and 2018, respectively. The decrease of $360.4 million, or 6.1% was primarily attributable to an 8.2%, 4.8% and 1.5% decrease in revenue in PSG, ASG and ISG, respectively, which is further explained below. Revenue by reportable segment for each were as follows (dollars in millions):
text: (1) Certain of the amounts may not total due to rounding of individual amounts.
text: Revenue from PSG
text: Revenue from PSG decreased by $249.9 million, or approximately 8%, which was due to a combination of a decrease in volume of products sold and a competitive pricing environment. The revenue in our Protection and Signal Division, Integrated Circuits Division, and High Power Division, decreased by $106.5 million, $96.6 million and $91.5 million, respectively. This was partially offset by an increase in revenue of $30.1 million and $15.0 million from our Foundry Services and Power Mosfet Division, respectively.
text: Revenue from ASG
text: Revenue from ASG decreased by $98.9 million, or approximately 5%, which was also due to a combination of a decrease in volume of products sold and a competitive pricing environment. The revenue in our Industrial and Offline Power Division and our Signal Processing, Wireless and Medical Division, decreased by $100.5 million and $56.4 million, respectively. This was partially offset by $84.8 million of revenue from Quantenna, which was acquired during 2019.
text: Revenue from ISG
text: Revenue from ISG decreased by $11.6 million, or 1.5%, which was due to a decrease in our Industrial Sensing Division revenue of $20.8 million, primarily due to decreased demand, which was partially offset by an increase in revenue in other divisions.

Table:
2019
As a % of Revenue (1)
2018
As a % of Revenue (1)
PSG
$ 2,788.3
50.5 %
$ 3,038.2
51.7 %
ASG
1,972.3
35.7 %
2,071.2
35.2 %
ISG
757.3
13.7 %
768.9
13.1 %
Total revenue
$ 5,517.9
$ 5,878.3

Questions:
text: 15. Trade and other payables
text: Trade and other payables mainly consist of amounts owed to suppliers that have been invoiced or are accrued and contract liabilities relating to consideration received from customers in advance. They also include taxes and social security amounts due in relation to the Group’s role as an employer. Derivative financial instruments with a negative market value are reported within this note.
text: Accounting policies
text: Trade payables are not interest-bearing and are stated at their nominal value.
text: Notes: 1 Previously described as deferred income in the year ended 31 March 2018
text: 2 Items are measured at fair value and the valuation basis is level 2 classification, which comprises items where fair value is determined from inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly
text: 3 Includes €823 million (2018: €nil) payable in relation to the irrevocable and non-discretionary share buyback programme announced in January 2019.
text: The carrying amounts of trade and other payables approximate their fair value.
text: Materially all of the €1,716 million recorded as current contract liabilities at 1 April 2018 was recognised as revenue during the year.
text: Other payables included within non-current liabilities include €288 million (2018: €271 million) in respect of the re-insurance of a third party annuity policy related to the Vodafone and CWW Sections of the Vodafone UK Group Pension Scheme.
text: The fair values of the derivative financial instruments are calculated by discounting the future cash flows to net present values using appropriate market interest rates and foreign currency rates prevailing at 31 March.

Table:
2019
2018
€m
€m
Included within non-current liabilities:
Other payables
327
314
Accruals
113
159
Contract liabilities1
574
237
Derivative financial instruments2
1,924
2,133
2,938
2,843
Included within current liabilities:
Trade payables
6,541
6,185
Amounts owed to associates and joint ventures
26
27
Other taxes and social security payable
1,218
1,177
Other payables3
1,410
1,346
Accruals
6,120
5,579
Contract liabilities1
1,818
1,678
Derivative financial instruments2
520
250
17,653
16,242

Questions:
question: Which financial years' information is shown in the table?
answer: 2018
2019
question: How much is the 2019 other payables included within non-current liabilities?
answer: 327
scale: million
question: How much is the 2018 other payables included within non-current liabilities?
answer: 314
scale: million
question: Between 2018 and 2019, which year had higher total trade and other payables included within current liabilities?
answer: 2019
derivation: 17,653>16,242
question: Between 2018 and 2019, which year had higher accruals included within non-current liabilities?
answer: 2018
derivation: 159>113
text: Other income and expenses, net consisted of the following:
text: The Company receives significant public funding from governmental agencies in several jurisdictions. Public funding for research and development is recognized ratably as the related costs are incurred once the agreement with the respective governmental agency has been signed and all applicable conditions have been met.
text: R&D funding received in the year ended December 31, 2017 from the Nano2017 program with the French government is subject to a financial return in the year 2024 and depends on the future cumulative sales of a certain product group from 2019 to 2024. As such, an accrual amounting to $47 million was recorded as of December 31, 2019 compared to $42 million as of December 31, 2018.
text: Phase-out costs are costs incurred during the closing stage of a Company’s manufacturing facility. They are treated in the same manner as start-up costs. Start-up costs represent costs incurred in the start-up and testing of the Company’s new manufacturing facilities, before reaching the earlier of a minimum level of production or six months after the fabrication line’s quality certification.
text: Exchange gains and losses, net represent the portion of exchange rate changes on transactions denominated in currencies other than an entity’s functional currency and the changes in fair value of trading derivative instruments which are not designated as hedge and which have a cash flow effect related to operating transactions, as described in Note 27.
text: Patent costs include legal and attorney fees and payment for claims, patent pre-litigation consultancy and legal fees. They are reported net of settlements, if any, which primarily include reimbursements of prior patent litigation costs.
text: In 2019, gain on sale of businesses and non-current assets was related to the sale of one of our non-strategic assets. In 2018, it was related to the sale of one of the Company’s non-strategic investments while in 2017, it
was related to the sale of assets.

Table:
Year ended December 31, 2019
Year ended December 31, 2018
Year ended December 31, 2017
Research and development funding
132
52
65
Phase-out and start-up costs
(38)
(1)
(8)
Exchange gain (loss), net
—
4
4
Patent costs
(1)
(8)
(9)
Gain on sale of businesses and non-current assets
7
8
4
Other, net
3
(2)
(1)
Total
103
53
55

Questions:
question: What is the average Research and development funding?
answer: 83
derivation: (132+52+65) / 3
question: What is the average Phase-out and start-up costs?
answer: 15.67
derivation: (38+1+8) / 3
question: What is the average Patent costs?
answer: 6
derivation: (1+8+9) / 3
text: (C.5) Income Taxes
text: Judgments and Estimates
text: We are subject to changing tax laws in multiple jurisdictions within the countries in which we operate. Our ordinary business activities also include transactions where the ultimate tax outcome is uncertain due to different interpretations of tax laws, such as those involving revenue sharing and cost reimbursement arrangements between SAP Group entities. In addition, the amount of income taxes we pay is generally subject to ongoing audits by domestic and foreign tax authorities. In determining our worldwide income tax provisions, judgment is involved in assessing whether to consider each uncertain tax treatment separately or together with one or more other uncertain tax treatments and whether to reflect the respective effect of uncertainty based on the most likely amount or the expected value. In applying these judgments, we consider the nature and the individual facts and circumstances of each uncertain tax treatment as well as the specifics of the respective jurisdiction, including applicable tax laws and our interpretation thereof.
text: The assessment whether a deferred tax asset is impaired requires judgment, as we need to estimate future taxable profits to determine whether the utilization of the deferred tax asset is probable. In evaluating our ability to utilize our deferred tax assets, we consider all available positive and negative evidence, including the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are recoverable. Our judgment regarding future taxable income is based on assumptions about future market conditions and future profits of SAP.
text: Judgment is also required in evaluating whether interest or penalties related to income taxes meet the definition of income taxes, and, if not, whether it is of financial nature. In this judgment, we particularly consider applicable local tax laws and interpretations on IFRS by national standard setters in the area of group financial reporting.
text: Tax Expense by Geographic Location

Table:
€ millions
2019
2018
2017
Current tax expense
Germany
625
733
935
Foreign
1,153
1,019
716
Total current tax expense
1,778
1,752
1,651
Deferred tax expense/income
Germany
–3
57
–584
Foreign
–549
–298
–84
Total deferred tax income
–552
–241
–668
Total income tax expense
1,226
1,511
983

Questions:
question: In which year was the current tax expense in Germany the largest?
answer: 2017
derivation: 935>733>625
question: What was the change in current tax expense in Germany in 2019 from 2018?
answer: -108
derivation: 625-733
scale: million
question: What was the percentage change in current tax expense in Germany in 2019 from 2018?
answer: -14.73
derivation: (625-733)/733
scale: percent
text: Research and Development
text: The increase in research and development expenses in fiscal 2019 compared to fiscal 2018 was primarily driven by an increase in employee compensation costs caused by increases in headcount, annual compensation and benefit adjustments and employee performance-based compensation, partially offset by a decrease in project material costs.

Table:
Fiscal Year Ended
December 28, 2019
December 29, 2018
$ Change
% Change
(Dollars in thousands)
Research and development
$81,499
$74,976
$6,523
8.7 %
% of revenues
13.8 %
14.2 %
Fiscal Year Ended
December 29, 2018
December 30, 2017
$ Change
% Change
(Dollars in thousands)
Research and development
$74,976
$73,807
$1,169
1.6 %
% of revenues
14.2 %
13.5 %

Questions:
question: What is the average Research and development for the Fiscal Year Ended December 28, 2019 to December 29, 2018?  
answer: 78237.5
derivation: (81,499+74,976) / 2
scale: thousand
question: What is the average Research and development for the Fiscal Year Ended December 29, 2018 to December 30, 2017?
answer: 74391.5
derivation: (74,976+73,807) / 2
scale: thousand
question: In which year was Research and development less than 80,000 thousands?
answer: 2018
derivation: locate and analyze Research and development in row 4
question: What was the % of revenues in 2019 and 2018?
answer: 13.8 %
14.2 %
question: What was the change in Research and development from 2018 to 2019?
answer: $6,523
scale: thousand
text: Commitments and Contractual Obligations
text: As of June 30, 2019, we have entered into the following contractual obligations with minimum payments for the indicated fiscal periods as follows:
text: 1) Includes interest up to maturity and principal payments. Please see note 10 "Long-Term Debt" for more details.
text: (2) Net of $30.7 million of sublease income to be received from properties which we have subleased to third parties.

Table:
Payments due between
Total
July 1, 2019— June 30, 2020
July 1, 2020— June 30, 2022
July 1, 2022— June 30, 2024
July 1, 2024 and beyond
Long-term debt obligations (1)
$3,408,565
$147,059
$292,156
$1,045,567
$1,923,783
Operating lease obligations (2)
318,851
72,853
106,394
59,441
80,163
Purchase obligations
11,280
8,364
2,747
169
—
$3,738,696
$228,276
$401,297
$1,105,177
$2,003,946

Questions:
question: What is the average annual fiscal year Long-term debt obligations for fiscal year 2020 to 2024?
answer: 296956.4
derivation: (147,059+292,156+1,045,567)/5
scale: thousand
question: What is the Total obligations of July 1, 2024 and beyond expressed as a percentage of Total obligations?
answer: 53.6
derivation: 2,003,946/3,738,696
scale: percent
question: For July 1, 2024 and beyond, what is Long-term debt obligations expressed as a percentage of Total obligations?
answer: 96
derivation: 1,923,783/2,003,946
scale: percent
text: Provision (Benefit) For Income Taxes
text: Provision for income taxes reflects the tax provision on our operations in foreign and U.S. jurisdictions, offset by tax benefits from a partial release of valuation allowance against U.S. federal and state deferred tax assets ("DTAs") and from lapsing of statute of limitations related to uncertain tax positions in foreign jurisdictions. As of December 28, 2019, we maintain a valuation allowance of $36.6 million primarily against our California deferred tax assets and foreign tax credits, due to uncertainty about the future realization of these assets.
text: The benefit for income taxes in fiscal 2018 includes a $75.8 million reduction to our valuation allowance on our U.S. deferred tax assets as sufficient positive evidence existed to support the realization of such DTAs. The effective tax rate in fiscal 2018 also benefited from a lower statutory tax rate in the U.S., partially offset by higher profits in foreign jurisdictions.
text: Our effective tax rate may vary from period to period based on changes in estimated taxable income or loss by jurisdiction, changes to the valuation allowance, changes to U.S. federal, state or foreign tax laws, future expansion into areas with varying country, state, and local income tax rates, deductibility of certain costs and expenses by jurisdiction.

Table:
Fiscal Year Ended
December 28, 2019
December 29, 2018
December 30, 2017
(Dollars in thousands)
Provision (benefit) for income taxes
$11,717
$(70,109)
$1,293
Effective tax rate
22.9 %
(206.6) %
3.1 %

Questions:
question: What is the change in Provision (benefit) for income taxes from Fiscal Year Ended December 28, 2019 to December 29, 2018?
answer: 81826
derivation: 11,717-(70,109)
scale: thousand
question: What is the change in Provision (benefit) for income taxes from Fiscal Year Ended December 29, 2018 to December 30, 2017?
answer: -71402
derivation: (70,109)-1,293
scale: thousand
question: In which year was Provision (benefit) for income taxes greater than 10,000 thousands?
answer: 2019
derivation: locate and analyze Provision (benefit) for income taxes in row 4
question: What was the Effective tax rate in 2018 and 2017 respectively?
answer: (206.6) %
3.1 %
scale: percent
text: Note 19 – Summarized Quarterly Financial Data (Unaudited)
text: The following table presents unaudited quarterly operating results for each of our last eight fiscal quarters. This information has been prepared on a basis consistent with our audited financial statements and includes all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair presentation of the data.
text: UNAUDITED QUARTERLY OPERATING RESULTS
text: (In thousands, except for per share amounts)
text: (1) Assumes exercise of dilutive securities calculated under the treasury stock method.

Table:
Three Months Ended
March 31, 2019
June 30, 2019
September 30, 2019
December 31, 2019
Net sales
$143,791
$156,391
$114,092
$115,787
Gross profit
$60,612
$65,015
$46,331
$47,209
Operating income (loss)
$(6,167)
$562
$(20,288)
$(14,070)
Net income (loss)
$770
$3,995
$(46,123)
$(11,624)
Earnings (loss) per common share - basic
$0.02
$0.08
$(0.96)
$(0.25)
Earnings (loss) per common share - diluted
$0.02(1)
$0.08(1)
$(0.96)
$(0.25)

Questions:
question: What was the percentage change in Net sales between Three Months Ended  September and December in 2019?
answer: 1.49
derivation: ( $115,787 - $114,092 )/ $114,092 
scale: percent
text: 2019 Performance Target and Payout: The ultimate number of our PBRS that vest, can range between 0% to 200%, and will be based on our achievement of the absolute Adjusted EBITDA Run Rate target (measured from fourth quarter of 2018 to fourth quarter of 2020), as illustrated in the table below.
text: (1) Determined by dividing (i) the Adjusted EBITDA actually attained for the fourth quarter of 2020 minus the Adjusted EBITDA actually attained for the fourth quarter of 2018 by (ii) the Adjusted EBITDA actually attained for the fourth quarter of 2018.
text: (2) Linear interpolation is used when our Adjusted EBITDA Run Rate performance is between the threshold, target and maximum amounts to determine the corresponding percentage of target award earned.

Table:
Performance Level
Adjusted EBITDA Run Rate(1)
Payout as % of Target Award(2)
Maximum
≥ 2.8%
200%
Target
0.0%
100%
Threshold
(2.8)%
50%
Below Threshold
< (2.8)%
0%

Questions:
question: What are the different performance levels?
answer: Maximum
Target
Threshold
Below Threshold
question: How many different performance levels are there?
answer: 4
derivation: Maximum##Target##Threshold##Below Threshold
question: How many performance levels would the payout as % of target award be above 50%?
answer: 2
derivation: Maximum##Target
question: What is the difference in the ratios of the payout expressed as % of Target Award for Maximum over Target compared against Target over Threshold?
answer: 0
derivation: (200%/100%)-(100%/50%)